How do you pay?

How to pay the least

Lowest price

$277.28 for 30 capsules delivered ($272.03 plus $5.25 shipping)

Generic metronidazole 375 mg from Cost Plus Drugs, by mail

  1. Make a free account on costplusdrugs.com. Ask your prescriber to send the prescription there, or Cost Plus Drugs can transfer it.Open Cost Plus Drugs 
  2. Order generic metronidazole 375 mg. It comes by mail.

A regular generic has the same active ingredient as Flagyl, and the FDA requires it to work the same way.

Compare every option

Question
Brand nameFlagyl
Authorized genericmetronidazole
Regular genericmetronidazole
What you’d pay
Cash priceAsk the pharmacyUsually the highest price
Not soldThere isn’t one
Lowest$277.28for 30 capsules at Cost Plus Drugs, with shipping
Same as Flagyl?
The original
–
Same active ingredientFillers and dyes can differ

Brand nameNo maker’s card

We didn’t find a savings card or cash price from Flagyl’s maker. Ask the pharmacy for Flagyl’s cash price. With insurance, ask what your plan charges.

Authorized genericNot sold

There isn’t one. An authorized generic is Flagyl itself, from the same company, sold without the brand name, and usually for less. A regular generic is sold, with the same active ingredient: ask the pharmacy for its price.

See the regular generic →

Regular genericWhere to buy it

Pharmacies’ own cash prices for generic metronidazole, lowest first.

Delivered

From each pharmacy’s own site, read November 2, 2026. Confirm the price before you fill.

About these prices

Prices change, can differ by store and state, and may depend on the strength and how many you take. With insurance, ask what your plan charges; it can be less.

Regular genericWho makes it

2 companies sell a generic of Flagyl that the FDA rates a substitute. A pharmacy fills whichever one it stocks. To get a certain maker, ask for it by name; most pharmacies can order it in a day or two.

  • Alembic Pharmaceuticals375 mg

    Has a dye: FD&C Yellow No. 5

    How it looks, what’s in it, NDCs

    375 mg Opaque gray opaque yellow, capsule, 19 mm, marked “HP66 / HP66”

    PackageNDC
    Bottle of 3062332-018-30
    Bottle of 5062332-018-50
    Bottle of 10062332-018-31
    Bottle of 50062332-018-71
    Bottle of 100062332-018-91

    Inactive ingredients: starch, corn, magnesium stearate, gelatin, titanium dioxide, FD&C Yellow No. 5, ferrosoferric oxide

    FDA label

  • Chartwell RX375 mg

    Has dyes: FD&C Blue No. 1, FD&C Red No. 3

    How it looks, what’s in it, NDCs

    375 mg White opaque body and Blue Opaque Cap, capsule, 19 mm, marked “CE / 26”

    PackageNDC
    Bottle of 5062135-836-50

    Inactive ingredients: butyl alcohol, ferrosoferric oxide, propylene glycol, shellac, ammonia, potassium hydroxide, titanium dioxide, starch, corn, alcohol, FD&C Blue No. 1, FD&C Red No. 3, magnesium stearate, isopropyl alcohol

    FDA label

Who sells it: FDA and Medicaid records, updated weekly. Each maker’s page, card and program is from its own site.

What to say at the pharmacy

“Before you fill my Flagyl, can you tell me what I’d pay for the brand and for a generic?”

Paying cash? Ask for each one’s cash price. With insurance, ask what your plan charges for each.

What it’s used for

What the FDA label says

Symptomatic Trichomoniasis. FLAGYL 375 capsules are indicated for the treatment of T. vaginalis infection in females and males when the presence of the trichomonad has been confirmed by appropriate laboratory procedures (wet smears and/or cultures).

Asymptomatic Trichomoniasis. FLAGYL 375 capsules are indicated in the treatment of asymptomatic T. vaginalis infection in females when the organism is associated with endocervicitis, cervicitis, or cervical erosion. Since there is evidence that presence of the trichomonad can interfere with accurate assessment of abnormal cytological smears, additional smears should be performed after eradication of the parasite.

Treatment of Asymptomatic Sexual Partners. T. vaginalis infection is a venereal disease. Therefore, asymptomatic sexual partners of treated patients should be treated simultaneously if the organism has been found to be present, in order to prevent reinfection of the partner. The decision as to whether to treat an asymptomatic male partner who has a negative culture or one for whom no culture has been attempted is an individual one. In making this decision, it should be noted that there is evidence that a woman may become reinfected if her sexual partner is not treated. Also, since there can be considerable difficulty in isolating the organism from the asymptomatic male carrier, negative smears and cultures cannot be relied upon in this regard. In any event, the sexual partner should be treated with metronidazole in cases of reinfection.

Amebiasis. FLAGYL 375 capsules are indicated in the treatment of acute intestinal amebiasis (amebic dysentery) and amebic liver abscess.

In amebic liver abscess, FLAGYL 375 capsules therapy does not obviate the need for aspiration or drainage of pus.

Anaerobic Bacterial Infections. FLAGYL 375 capsules are indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. Indicated surgical procedures should be performed in conjunction with FLAGYL therapy. In a mixed aerobic and anaerobic infection, antimicrobials appropriate for the treatment of the aerobic infection should be used in addition to FLAGYL 375 capsules.

INTRA-ABDOMINAL INFECTIONS, including peritonitis, intra-abdominal abscess, and liver abscess, caused by Bacteroides species including the B. fragilis group (B. fragilis, B. distasonis, B. ovatus, B. thetaiotaomicron, B. vulgatus), Clostridium species, Eubacterium species, Peptococcus species, or Peptostreptococcus species.

SKIN AND SKIN STRUCTURE INFECTIONS caused by Bacteroides species including the B. fragilis group, Clostridium species, Peptococcus species, Peptostreptococcus species, or Fusobacterium species.

GYNECOLOGIC INFECTIONS, including endometritis, endomyometritis, tubo-ovarian abscess, and postsurgical vaginal cuff infection, caused by Bacteroides species including the B. fragilis group, Clostridium species, Peptococcus species, Peptostreptococcus species, or Fusobacterium species.

BACTERIAL SEPTICEMIA caused by Bacteroides species including the B. fragilis group or Clostridium species.

BONE AND JOINT INFECTIONS (as adjunctive therapy) caused by Bacteroides species including the B. fragilis group.

CENTRAL NERVOUS SYSTEM (CNS) INFECTIONS, including meningitis and brain abscess, caused by Bacteroides species including the B. fragilis group.

LOWER RESPIRATORY TRACT INFECTIONS, including pneumonia, empyema, and lung abscess, caused by Bacteroides species including the B. fragilis group.

ENDOCARDITIS caused by Bacteroides species including the B. fragilis group.

To reduce the development of drug-resistant bacteria and maintain the effectiveness of FLAGYL 375 capsules and other antibacterial drugs, FLAGYL 375 capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.

Source: the FDA label for Flagyl (Pfizer Laboratories Div Pfizer Inc), May 22, 2026. Full label on DailyMed 

Good to know